EA201690335A1 - Новые средства для уменьшения негативных последствий курения - Google Patents

Новые средства для уменьшения негативных последствий курения

Info

Publication number
EA201690335A1
EA201690335A1 EA201690335A EA201690335A EA201690335A1 EA 201690335 A1 EA201690335 A1 EA 201690335A1 EA 201690335 A EA201690335 A EA 201690335A EA 201690335 A EA201690335 A EA 201690335A EA 201690335 A1 EA201690335 A1 EA 201690335A1
Authority
EA
Eurasian Patent Office
Prior art keywords
smoking
reduce
negative consequences
new means
elastase inhibitor
Prior art date
Application number
EA201690335A
Other languages
English (en)
Inventor
Герард Форман
Фрисо Мартийн Форман
Original Assignee
Герард Форман
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Герард Форман filed Critical Герард Форман
Publication of EA201690335A1 publication Critical patent/EA201690335A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00—Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • A—HUMAN NECESSITIES
    • A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
    • A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
    • A24D3/17—Filters specially adapted for simulated smoking devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Cigarettes, Filters, And Manufacturing Of Filters (AREA)
  • Medicinal Preparation (AREA)

Abstract

Настоящее изобретение относится к применению ингибитора эластазы, предпочтительно фахзина, для лечения или предотвращения эмфиземы, ХОБЛ или рака легких. Ингибитор эластазы предпочтительно вводят посредством вдыхания, предпочтительно посредством вдыхания табачного дыма. Настоящее изобретение также включает изделия для курения, содержащие такой ингибитор эластазы.
EA201690335A 2013-08-05 2014-08-05 Новые средства для уменьшения негативных последствий курения EA201690335A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP2013066415 2013-08-05
PCT/EP2014/066844 WO2015018840A2 (en) 2013-08-05 2014-08-05 Novel means to decrease the negative effects of smoking

Publications (1)

Publication Number Publication Date
EA201690335A1 true EA201690335A1 (ru) 2016-09-30

Family

ID=48916083

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690335A EA201690335A1 (ru) 2013-08-05 2014-08-05 Новые средства для уменьшения негативных последствий курения

Country Status (9)

Country Link
US (2) US20160177285A1 (ru)
EP (1) EP3030254A2 (ru)
JP (1) JP2016528234A (ru)
KR (1) KR20160054475A (ru)
CN (1) CN105592854A (ru)
AU (1) AU2014304578A1 (ru)
CA (1) CA2920452A1 (ru)
EA (1) EA201690335A1 (ru)
WO (1) WO2015018840A2 (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10244793B2 (en) 2005-07-19 2019-04-02 Juul Labs, Inc. Devices for vaporization of a substance
US10279934B2 (en) 2013-03-15 2019-05-07 Juul Labs, Inc. Fillable vaporizer cartridge and method of filling
USD842536S1 (en) 2016-07-28 2019-03-05 Juul Labs, Inc. Vaporizer cartridge
US10058129B2 (en) 2013-12-23 2018-08-28 Juul Labs, Inc. Vaporization device systems and methods
USD825102S1 (en) 2016-07-28 2018-08-07 Juul Labs, Inc. Vaporizer device with cartridge
US10076139B2 (en) 2013-12-23 2018-09-18 Juul Labs, Inc. Vaporizer apparatus
US20160366947A1 (en) 2013-12-23 2016-12-22 James Monsees Vaporizer apparatus
US10159282B2 (en) 2013-12-23 2018-12-25 Juul Labs, Inc. Cartridge for use with a vaporizer device
AU2014369867A1 (en) 2013-12-23 2016-06-16 Juul Labs, Inc. Vaporization device systems and methods
EP3821735A1 (en) 2014-12-05 2021-05-19 Juul Labs, Inc. Calibrated dose control
BR112018016402B1 (pt) 2016-02-11 2023-12-19 Juul Labs, Inc Cartuchos de fixação segura para dispositivos vaporizadores
MX2018009702A (es) 2016-02-11 2019-07-08 Juul Labs Inc Cartucho rellenable de vaporizador y metodo de relleno.
US10405582B2 (en) 2016-03-10 2019-09-10 Pax Labs, Inc. Vaporization device with lip sensing
FR3049866B1 (fr) 2016-04-07 2019-09-06 Nfl Biosciences Extrait de feuilles de tabac et utilisation pour le traitement de l'addiction au tabac
USD849996S1 (en) 2016-06-16 2019-05-28 Pax Labs, Inc. Vaporizer cartridge
USD836541S1 (en) 2016-06-23 2018-12-25 Pax Labs, Inc. Charging device
USD851830S1 (en) 2016-06-23 2019-06-18 Pax Labs, Inc. Combined vaporizer tamp and pick tool
USD887632S1 (en) 2017-09-14 2020-06-16 Pax Labs, Inc. Vaporizer cartridge
TW202104895A (zh) * 2019-01-11 2021-02-01 日商日本煙草產業股份有限公司 抽煙或吸煙引起之慢性閉塞性肺疾病風險之體外評估方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996013585A1 (en) * 1994-10-28 1996-05-09 Clodica S.A. A novel family of protease inhibitors, and other biologic active substances
AU2005221151A1 (en) * 2004-03-09 2005-09-22 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
US8646461B2 (en) * 2011-12-14 2014-02-11 Sentiens, Llc Device and method for simulating chemosensation of smoking
CN103889436A (zh) * 2011-12-30 2014-06-25 基立福有限公司 用于延迟肺部症状加重的发作或进展的α1-蛋白酶抑制剂

Also Published As

Publication number Publication date
WO2015018840A3 (en) 2015-04-16
KR20160054475A (ko) 2016-05-16
JP2016528234A (ja) 2016-09-15
EP3030254A2 (en) 2016-06-15
CN105592854A (zh) 2016-05-18
AU2014304578A1 (en) 2016-03-24
WO2015018840A2 (en) 2015-02-12
CA2920452A1 (en) 2015-02-12
US20160177285A1 (en) 2016-06-23
US20190359963A1 (en) 2019-11-28

Similar Documents

Publication Publication Date Title
EA201690335A1 (ru) Новые средства для уменьшения негативных последствий курения
CY1123391T1 (el) (2s)-n-[(1s)-1-kyano-2-φainyλaιθyλ]-1,4-oξazeπan-2-καρβοξαμιδια ως αναστολεις της διπεπτιδυλικης πεπτιδασης ι
EA201690760A1 (ru) Производные карбоксамида и их применение в качестве медикаментов для лечения гепатита b
EA201690277A1 (ru) Производные замещенного глиоксамидом пирроламида и их применение в качестве лекарственных средств для лечения гепатита b
CY1119227T1 (el) Παραγωγα πυριδινης ως ηπιοι αναστολεις της rock
GEP20186921B (en) Pyrazolopyridines and pyrazolopyrimidines
EA201691579A1 (ru) Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
EA201592200A1 (ru) Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
EA201592198A1 (ru) Производные сульфамоилтиофенамида и их применение в качестве медикаментов для лечения гепатита b
EA201591586A1 (ru) Сульфамоил-ариламиды и их применение в качестве лекарственных препаратов для лечения гепатита b
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
EA201692481A1 (ru) Комбинация, содержащая глюкокортикоид и edo-s101
MX2015013224A (es) Inhibidores macrociclicos y biciclicos del virus de la hepatitis c.
EA201690763A1 (ru) Лечение рака поджелудочной железы
MX2019013468A (es) Metodos para tratar la enfermedad pulmonar obstructiva cronica usando benralizumab.
EA201690561A1 (ru) Пептидилнитрильные соединения в качестве ингибиторов дипептидилпептидазы i
EA201600002A1 (ru) Производные пролекарства замещенных триазолопиридинов
EA201500737A1 (ru) Пиразолилкарбоксамиды ii в качестве ингибиторов crac каналов
EA201792282A1 (ru) Способы лечения заболеваний
PH12016502480A1 (en) Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases
WO2014180882A3 (en) Treatment of brain metastasis from cancer
EA201892421A1 (ru) Новый сигаретный фильтр, содержащий альгинит
PH12016501808A1 (en) Chemical compounds
EA202092842A3 (ru) Производные сульфамоилпирроламида и их применение в качестве медикаментов для лечения гепатита b
PH12015502304A1 (en) Use of pidotimod to treat irritable bowel syndrome